Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

KRAS mutation and DNA repair and synthesis genes in non-small-cell lung cancer.

Ludovini V, Ricciuti B, Tofanetti FR, Mencaroni C, Giannarelli D, Sidoni A, Reda MS, Siggillino A, Baglivo S, Crinò L, Bellezza G, Chiari R, Metro G.

Mol Clin Oncol. 2018 Dec;9(6):689-696. doi: 10.3892/mco.2018.1731. Epub 2018 Oct 1.

PMID:
30546903
2.

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab.

Madonna G, Ballesteros-Merino C, Feng Z, Bifulco C, Capone M, Giannarelli D, Mallardo D, Simeone E, Grimaldi AM, Caracò C, Botti G, Fox BA, Ascierto PA.

Oncoimmunology. 2018 Sep 5;7(12):e1405206. doi: 10.1080/2162402X.2017.1405206. eCollection 2018.

PMID:
30524879
3.

Perampanel in patients with brain tumour-related epilepsy in real-life clinical practice: a retrospective analysis.

Maschio M, Pauletto G, Zarabla A, Maialetti A, Ius T, Villani V, Fabi A, Koudriavtseva T, Giannarelli D.

Int J Neurosci. 2018 Dec 3:1-10. doi: 10.1080/00207454.2018.1555160. [Epub ahead of print]

PMID:
30507318
4.

Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia.

Reda G, Riva M, Fattizzo B, Cassin R, Giannarelli D, Pennisi M, Freyrie A, Cairoli R, Molteni A, Cortelezzi A.

Semin Hematol. 2018 Oct;55(4):202-208. doi: 10.1053/j.seminhematol.2018.02.005. Epub 2018 Feb 21. Review.

PMID:
30502848
5.

Peripherally inserted central catheter, midline, and "short" midline in palliative care: Patient-reported outcome measures to assess impact on quality of care.

Magnani C, Calvieri A, Giannarelli D, Espino M, Casale G.

J Vasc Access. 2018 Dec 3:1129729818814732. doi: 10.1177/1129729818814732. [Epub ahead of print]

PMID:
30501549
6.

The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis.

Molica S, Giannarelli D, Mirabelli R, Levato L, Shanafelt TD.

Leuk Lymphoma. 2018 Dec 5:1-6. doi: 10.1080/10428194.2018.1543882. [Epub ahead of print]

PMID:
30516079
7.

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.

Del Bene G, Calabrò F, Giannarelli D, Plimack ER, Harshman LC, Yu EY, Crabb SJ, Pal SK, Alva AS, Powles T, De Giorgi U, Agarwal N, Bamias A, Ladoire S, Necchi A, Vaishampayan UN, Niegisch G, Bellmunt J, Baniel J, Galsky MD, Sternberg CN.

Front Oncol. 2018 Nov 19;8:463. doi: 10.3389/fonc.2018.00463. eCollection 2018.

8.

Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.

Garassino MC, Crinò L, Catino A, Ardizzoni A, Cortesi E, Cappuzzo F, Bordi P, Calabrò L, Barbieri F, Santo A, Altavilla G, Ambrosio F, Mini E, Vasile E, Morgillo F, Scoppola A, Bengala C, Follador A, Tedde N, Giannarelli D, Lo Russo G, Vitiello F.

Tumour Biol. 2018 Nov;40(11):1010428318815047. doi: 10.1177/1010428318815047.

PMID:
30486741
9.

Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: a prospective observational study.

Torregiani G, Claroni C, Covotta M, Naccarato A, Canfora M, Giannarelli D, Grazi GL, Tribuzi S, Forastiere E.

J Comp Eff Res. 2018 Nov 19. doi: 10.2217/cer-2018-0041. [Epub ahead of print]

PMID:
30450955
10.

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.

Passiglia F, Cappuzzo F, Alabiso O, Bettini AC, Bidoli P, Chiari R, Defferrari C, Delmonte A, Finocchiaro G, Francini G, Gelsomino F, Giannarelli D, Giordano M, Illiano A, Livi L, Martelli O, Natoli C, Puppo G, Ricevuto E, Roca E, Turci D, Galetta D.

Br J Cancer. 2018 Oct 31. doi: 10.1038/s41416-018-0234-3. [Epub ahead of print]

PMID:
30377342
11.

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.

Bersanelli M, Giannarelli D, Castrignanò P, Fornarini G, Panni S, Mazzoni F, Tiseo M, Rossetti S, Gambale E, Rossi E, Papa A, Cortellini A, Lolli C, Ratta R, Michiara M, Milella M, De Luca E, Sorarù M, Mucciarini C, Atzori F, Banna GL, La Torre L, Vitale MG, Massari F, Rebuzzi SE, Facchini G, Schinzari G, Tomao S, Bui S, Vaccaro V, Procopio G, De Giorgi U, Santoni M, Ficorella C, Sabbatini R, Maestri A, Natoli C, De Tursi M, Di Maio M, Rapacchi E, Pireddu A, Sava T, Lipari H, Comito F, Verzoni E, Leonardi F, Buti S.

Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.

PMID:
30326787
12.

Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.

Magnani C, Giannarelli D, Calvieri A, Dardeli A, Eusepi G, Restuccia MR, Mastroianni C, Casale G.

Postgrad Med J. 2018 Oct;94(1116):566-570. doi: 10.1136/postgradmedj-2018-135659. Epub 2018 Oct 13.

PMID:
30317182
13.

Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data.

Maschio M, Zarabla A, Maialetti A, Marchesi F, Giannarelli D, Gumenyuk S, Pisani F, Renzi D, Galiè E, Mengarelli A.

Integr Cancer Ther. 2018 Dec;17(4):1115-1124. doi: 10.1177/1534735418803758. Epub 2018 Oct 8.

14.

A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients.

Molica S, Giannarelli D, Levato L, Mirabelli R, Levato D, Lentini M, Piro E.

Leuk Lymphoma. 2018 Oct 2:1-3. doi: 10.1080/10428194.2018.1508674. [Epub ahead of print] No abstract available.

PMID:
30277125
15.

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.

Fabi A, Alesini D, Valle E, Moscetti L, Caputo R, Caruso M, Carbognin L, Ciccarese M, La Verde N, Arpino G, Cannita K, Paris I, Santini D, Montemurro F, Russillo M, Ferretti G, Filippelli G, Rossello R, Fabbri A, Zambelli A, Leonardi V, D'Ottavio AM, Nisticò C, Stani S, Giampaglia M, Scandurra G, Catania G, Malaguti P, Giannarelli D, Cognetti F.

Breast. 2018 Oct;41:137-143. doi: 10.1016/j.breast.2018.07.004. Epub 2018 Jul 12.

PMID:
30092500
16.

Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.

Danielli R, Cisternino F, Giannarelli D, Calabrò L, Camerini R, Savelli V, Bova G, Dragonetti R, Di Giacomo AM, Altomonte M, Maio M.

Expert Opin Biol Ther. 2018 Jul;18(sup1):77-83. doi: 10.1080/14712598.2018.1494717.

PMID:
30063847
17.

Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients.

Annaloro C, Airaghi L, Giannarelli D, Mometto G, Orsatti A, Saporiti G, Grifoni FI, Baldini M, Tagliaferri E, Vincenti D, Maira D, Onida F, Cortelezzi A.

Ann Hematol. 2018 Dec;97(12):2471-2478. doi: 10.1007/s00277-018-3452-0. Epub 2018 Jul 27.

PMID:
30054704
18.

Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.

Grossi F, Crinò L, Logroscino A, Canova S, Delmonte A, Melotti B, Proto C, Gelibter A, Cappuzzo F, Turci D, Gamucci T, Antonelli P, Marchetti P, Santoro A, Giusti S, Di Costanzo F, Giustini L, Del Conte A, Livi L, Giannarelli D, de Marinis F.

Eur J Cancer. 2018 Sep;100:126-134. doi: 10.1016/j.ejca.2018.05.015. Epub 2018 Jul 13.

PMID:
30014881
19.

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.

Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, Vanella V, Simeone E, Paone M, Palmieri G, Cavalcanti E, Caracò C, Ascierto PA.

J Immunother Cancer. 2018 Jul 16;6(1):74. doi: 10.1186/s40425-018-0383-1.

20.

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.

De Giorgi U, Cartenì G, Giannarelli D, Basso U, Galli L, Cortesi E, Caserta C, Pignata S, Sabbatini R, Bearz A, Buti S, Lo Re G, Berruti A, Bracarda S, Cognetti F, Rastelli F, Fornarini G, Porta C, Turci D, Sternberg CN, Procopio G; Italian Nivolumab Renal Cell Cancer Early Access Program Group.

BJU Int. 2018 Jun 29. doi: 10.1111/bju.14461. [Epub ahead of print]

PMID:
29956884
21.

Do immune checkpoint inhibitors need new studies methodology?

Ferrara R, Pilotto S, Caccese M, Grizzi G, Sperduti I, Giannarelli D, Milella M, Besse B, Tortora G, Bria E.

J Thorac Dis. 2018 May;10(Suppl 13):S1564-S1580. doi: 10.21037/jtd.2018.01.131. Review.

22.

The Effectiveness of the Sport "Dragon Boat Racing" in Reducing the Risk of Lymphedema Incidence: An Observational Study.

Iacorossi L, Gambalunga F, Molinaro S, De Domenico R, Giannarelli D, Fabi A.

Cancer Nurs. 2018 Jun 22. doi: 10.1097/NCC.0000000000000615. [Epub ahead of print]

PMID:
29933309
23.

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.

Reda G, Fattizzo B, Cassin R, Mattiello V, Tonella T, Giannarelli D, Massari F, Cortelezzi A.

J Hematol Oncol. 2018 Jun 11;11(1):79. doi: 10.1186/s13045-018-0626-0.

24.

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.

Bracarda S, Galli L, Maruzzo M, Lo Re G, Buti S, Favaretto A, Di Costanzo F, Sacco C, Merlano M, Mucciarini C, Zafarana E, Romito S, Maestri A, Giorgio CG, Ionta MT, Turci D, De Giorgi U, Procopio G, Cortesi E, Giannarelli D, Porta C.

Future Oncol. 2018 Jun;14(14):1347-1354. doi: 10.2217/fon-2017-0570. Epub 2018 May 18.

PMID:
29774766
25.

Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study.

Calabrò L, Morra A, Giannarelli D, Amato G, D'Incecco A, Covre A, Lewis A, Rebelatto MC, Danielli R, Altomonte M, Di Giacomo AM, Maio M.

Lancet Respir Med. 2018 Jun;6(6):451-460. doi: 10.1016/S2213-2600(18)30151-6. Epub 2018 May 15.

PMID:
29773326
26.

Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis.

Molica S, Giannarelli D, Mirabelli R, Levato L, Shanafelt TD.

Ann Hematol. 2018 Oct;97(10):2005-2008. doi: 10.1007/s00277-018-3350-5. Epub 2018 May 8. Review. No abstract available.

PMID:
29740683
27.

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.

Garassino MC, Gelibter AJ, Grossi F, Chiari R, Soto Parra H, Cascinu S, Cognetti F, Turci D, Blasi L, Bengala C, Mini E, Baldini E, Quadrini S, Ceresoli GL, Antonelli P, Vasile E, Pinto C, Fasola G, Galetta D, Macerelli M, Giannarelli D, Lo Russo G, de Marinis F.

J Thorac Oncol. 2018 Aug;13(8):1146-1155. doi: 10.1016/j.jtho.2018.04.025. Epub 2018 May 3.

PMID:
29730379
28.

Supracricoid partial laryngectomy for radiorecurrent laryngeal cancer: a systematic review of the literature and meta-analysis.

De Virgilio A, Pellini R, Mercante G, Cristalli G, Manciocco V, Giannarelli D, Spriano G.

Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1671-1680. doi: 10.1007/s00405-018-4986-4. Epub 2018 Apr 30. Review.

PMID:
29713885
29.

Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients.

Metro G, Giannarelli D, Sidoni A, Chiari R, Bellezza G.

Int J Biol Markers. 2018 Apr 1:1724600818754763. doi: 10.1177/1724600818754763. [Epub ahead of print] No abstract available.

PMID:
29683065
30.

Inflatable Penile Prosthesis Placement, Scratch Technique and Postoperative Vacuum Therapy as a Combined Approach to Definitive Treatment of Peyronie's Disease.

Antonini G, De Berardinis E, Del Giudice F, Busetto GM, Lauretti S, Fragas R, Chung BI, Conti SL, Giannarelli D, Sperduti I, Gross MS, Perito PE.

J Urol. 2018 Sep;200(3):642-647. doi: 10.1016/j.juro.2018.04.060. Epub 2018 Apr 17.

PMID:
29678456
31.

[The impact of Reiki on side effects in patients with head-neck neoplasia undergoing radiotherapy: a pilot study].

Iacorossi L, Di Ridolfi P, Bigiarini L, Giannarelli D, Sanguineti G.

Prof Inferm. 2017 Oct-Dec;70(3):214-221. doi: 10.7429/pi.2017.704214. Italian.

PMID:
29460558
32.

Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.

Marchesi F, Vacca M, Giannarelli D, Ipsevich F, Pandolfi A, Gumenyuk S, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Pierelli L, Mengarelli A.

Transfusion. 2018 May;58(5):1143-1148. doi: 10.1111/trf.14533. Epub 2018 Feb 15.

PMID:
29446445
33.

BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.

Marchesi F, Capria S, Giannarelli D, Trisolini SM, Ansuinelli M, Caputo MD, Serrao A, Gumenyuk S, Renzi D, Pupo L, Palombi F, Provenzano I, Di Rocco A, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Cantonetti M, Mengarelli A.

Bone Marrow Transplant. 2018 Aug;53(8):1051-1054. doi: 10.1038/s41409-018-0120-x. Epub 2018 Feb 13. No abstract available.

PMID:
29440737
34.

Association between Helicobacter pylori infection and vulvar lichen sclerosus: a clinical comparative study.

Basile S, Pinelli S, Benedetti Panici P, Angioli R, Plotti F, Giannarelli D, Fossati R, Rosati CM, Salerno MG.

Eur J Dermatol. 2018 Apr 1;28(2):226-227. doi: 10.1684/ejd.2017.3207. No abstract available.

PMID:
29336317
35.

Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study.

Pinnarò P, Giordano C, Farneti A, Faiella A, Iaccarino G, Landoni V, Giannarelli D, Vici P, Strigari L, Sanguineti G.

J Exp Clin Cancer Res. 2017 Dec 27;36(1):191. doi: 10.1186/s13046-017-0640-z.

36.

Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.

Pinelli S, Artini PG, Basile S, Obino MER, Sergiampietri C, Giannarelli D, Simi G, Cela V.

J Assist Reprod Genet. 2018 Mar;35(3):475-482. doi: 10.1007/s10815-017-1096-y. Epub 2017 Dec 5.

PMID:
29204869
37.

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.

Morello S, Capone M, Sorrentino C, Giannarelli D, Madonna G, Mallardo D, Grimaldi AM, Pinto A, Ascierto PA.

J Transl Med. 2017 Dec 4;15(1):244. doi: 10.1186/s12967-017-1348-8.

38.

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi A, Giannarelli D, Moscetti L, Santini D, Zambelli A, Laurentiis M, Caruso M, Generali D, Valle E, Leonardi V, Cannita K, Arpino G, Filippelli G, Ferretti G, Giampaglia M, Montemurro F, Nisticò C, Gasparro S, Cognetti F.

Future Oncol. 2017 Dec;13(30):2791-2797. doi: 10.2217/fon-2017-0336. Epub 2017 Nov 28.

PMID:
29182361
39.

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.

Metro G, Passaro A, Lo Russo G, Bonanno L, Giusti R, Gregorc V, Capelletto E, Martelli O, Cecere FL, Giannarelli D, Luciani A, Bearz A, Tuzi A, Scotti V, Tonini G, Galetta D, Carta A, Soto Parra H, Rebonato A, Morabito A, Chiari R.

Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.

PMID:
29135281
40.

Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis.

Molica S, Giannarelli D, Mirabelli R, Levato L, Kay NE, Shanafelt TD.

Blood. 2018 Jan 18;131(3):365-368. doi: 10.1182/blood-2017-09-806034. Epub 2017 Oct 30. No abstract available.

PMID:
29084773
41.

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

Fabi A, De Laurentiis M, Caruso M, Valle E, Moscetti L, Santini D, Cannita K, Carbognin L, Ciccarese M, Rossello R, Arpino G, Leonardi V, Montemurro F, La Verde N, Generali D, Zambelli A, Scandurra G, Russillo M, Paris I, D'Ottavio AM, Filippelli G, Giampaglia M, Stani S, Fabbri A, Alesini D, Cianniello D, Giannarelli D, Cognetti F.

Oncotarget. 2017 Mar 18;8(38):64481-64489. doi: 10.18632/oncotarget.16373. eCollection 2017 Sep 8.

42.

Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial.

Piredda M, Facchinetti G, Biagioli V, Giannarelli D, Armento G, Tonini G, De Marinis MG.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12757. Epub 2017 Aug 25.

PMID:
28840622
43.

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.

Maccalli C, Giannarelli D, Chiarucci C, Cutaia O, Giacobini G, Hendrickx W, Amato G, Annesi D, Bedognetti D, Altomonte M, Danielli R, Calabrò L, Di Giacomo AM, Marincola FM, Parmiani G, Maio M.

Oncoimmunology. 2017 May 8;6(7):e1323618. doi: 10.1080/2162402X.2017.1323618. eCollection 2017.

44.

Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center.

Maschio M, Beghi E, Casazza MML, Colicchio G, Costa C, Banfi P, Quadri S, Aloisi P, Giallonardo AT, Buttinelli C, Pauletto G, Striano S, Salmaggi A, Terenzi R, Daniele O, Crichiutti G, Paladin F, Rossi R, Prato G, Vigevano F, De Simone R, Ricci F, Saladini M, Monti F, Casellato S, Zanoni T, Giannarelli D, Avanzini G, Aguglia U; BTRE Study Group.

PLoS One. 2017 Jul 17;12(7):e0180470. doi: 10.1371/journal.pone.0180470. eCollection 2017.

45.

Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.

Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D.

Epilepsy Behav. 2017 Aug;73:83-89. doi: 10.1016/j.yebeh.2017.05.031. Epub 2017 Jun 14.

PMID:
28623754
46.

Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.

Marucci L, Farneti A, Di Ridolfi P, Pinnaro P, Pellini R, Giannarelli D, Vici P, Conte M, Landoni V, Sanguineti G.

Head Neck. 2017 Sep;39(9):1761-1769. doi: 10.1002/hed.24832. Epub 2017 May 31.

PMID:
28560780
47.

The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC).

Nicolazzo C, Busetto GM, Del Giudice F, Sperduti I, Giannarelli D, Gradilone A, Gazzaniga P, de Berardinis E, Raimondi C.

J Cancer Res Clin Oncol. 2017 Oct;143(10):1971-1976. doi: 10.1007/s00432-017-2449-8. Epub 2017 May 29.

PMID:
28555356
48.

Laser-assisted hatching of human embryos: may two alternative approaches (thinning versus drilling) impact on implant rate?

Padula F, Capriglione S, Iaconianni P, Gatti S, Lippa A, Minutolo SE, Giannarelli D, Giorlandino C.

Lasers Med Sci. 2017 Sep;32(7):1663-1666. doi: 10.1007/s10103-017-2242-6. Epub 2017 May 25. No abstract available.

PMID:
28547074
49.

Erratum to: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.

Di Filippo F, Di Filippo S, Ferrari AM, Antonetti R, Battaglia A, Becherini F, Bernet L, Boldorini R, Bouteille C, Buglioni S, Burelli P, Cano R, Canzonieri V, Chiodera P, Cirilli A, Coppola L, Drago S, Di Tommaso L, Fenaroli P, Franchini R, Gianatti A, Giannarelli D, Giardina C, Godey F, Grassi MM, Grassi GB, Laws S, Massarut S, Naccarato G, Natalicchio MI, Orefice S, Palmieri F, Perin T, Roncella M, Roncalli MG, Rulli A, Sidoni A, Tinterri C, Truglia MC, Sperduti I.

J Exp Clin Cancer Res. 2017 May 16;36(1):69. doi: 10.1186/s13046-017-0540-2. No abstract available.

50.

The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?

Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P.

Breast. 2017 Aug;34:44-52. doi: 10.1016/j.breast.2017.04.012. Epub 2017 May 11.

Supplemental Content

Loading ...
Support Center